pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
pre-IPO PHARMA NEWS
Business
05/05/22
Phosplatin Therapeutics Adopts New Corporate Name as Promontory Therapeutics Inc.
05/05/22
Flare Therapeutics to Present at the Bank of America Securities 2022 Healthcare Conference
05/05/22
Curebase Secures $40 Million in Series B Funding
05/04/22
Enteris BioPharma to Exhibit at CPhI North America 2022
05/04/22
Apnimed Announces $62.5 Million Series C Financing to Advance Development of Novel Pharmaceutical Treatments for Obstructive Sleep Apnea (OSA) and Related Sleep Disorders
05/04/22
Mologic and Alamar Biosciences collaborate to develop a next generation COVID-19 antigen test
05/03/22
Tevogen Bio Expands Research and Development Capacity at CIC Philadelphia to Accommodate its Expanding Product Portfolio
05/03/22
NiKang Therapeutics and Hansoh Pharma Announce Strategic Collaboration and License Agreement for NKT2152 in Greater China
05/03/22
Lutris Pharma to Present at the Bio€quity Europe Conference USA - English USA - English USA - English
05/03/22
Genesis Therapeutics Announces Strategic Collaboration with Lilly to Discover Novel Therapies Using the Genesis Molecular AI Platform
05/03/22
DepYmed Receives FDA Rare Pediatric Disease and Orphan Drug Designations for Its Lead Clinical Candidate for the Treatment of Rett Syndrome
05/03/22
Dianthus Therapeutics Launches with $100M to Develop Selective Antibody Complement Therapeutics to Treat Severe and Rare Autoimmune Diseases
05/03/22
Arbor Biotechnologies to Present at the Bank of America Global Healthcare Conference
05/03/22
Adiso Therapeutics to Present at BioNJ's 12th Annual BioPartnering Conference
05/02/22
Scribe Therapeutics Expands Collaboration With Biogen to Second Target
05/02/22
Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Nevakar
04/29/22
Biocytogen Enters into Antibody Agreement with Merck KGaA, Darmstadt, Germany
04/28/22
FDA Approves Mycovia Pharmaceuticals’ VIVJOA™ (oteseconazole), the First and Only FDA-Approved Medication for Recurrent Vulvovaginal Candidiasis (Chronic Yeast Infection)
04/27/22
Myeloid Therapeutics to Participate in Morgan Stanley Private Company Biotech Corporate Access Day
04/27/22
Cellectis reçoit une note convertible de 20 millions de dollars dans le cadre de l’accord de collaboration avec son partenaire Cytovia Therapeutics
Science
05/05/22
NKGen Biotech to Present at the American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting
05/05/22
Metagenomi to Present New Preclinical Data at the Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
05/05/22
Medicago Announces Publication of Phase 3 COVID-19 Vaccine Study Results in New England Journal of Medicine
05/05/22
CODA Biotherapeutics Announces Preclinical Data From Epilepsy Program to be Presented at American Society of Gene and Cell Therapy 25th Annual Meeting
05/04/22
Starton Therapeutics Provides Update on STAR-LLD Lenalidomide Clinical Program
05/04/22
Melt Pharmaceuticals Announces MELT-210 Top-Line Results of Phase 1 Pharmacokinetics (PK) Study for Procedural Sedation
05/04/22
ElevateBio Announces Presentation on Lentiviral Vector Platform at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
05/03/22
ReCode Therapeutics to Present Preclinical Data Using Proprietary SORT LNP Delivery Platform From Its mRNA-based Therapeutic Programs at the ATS 2022 International Conference in San Francisco
05/03/22
NanOlogy Publishes Results from a Phase 1/2 Clinical Trial of its Topical Investigational Drug in the Treatment of Cutaneous Metastases of Breast Cancer
05/03/22
Metagenomi Presents Findings on Novel Families of Ultra Small, CRISPR Enzymes at the Keystone Symposia Precision Genome Engineering Conference
05/03/22
LEXEO Therapeutics Announces Data Presentations at the 25th American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
05/03/22
Avilar Therapeutics Executives to be Featured Speakers on Advances in Protein Degradation at Upcoming Drug Discovery Conferences
05/03/22
ACELYRIN, INC., Affibody AB, and Inmagene Bio Announce Positive Results from Global Phase 2 Trial of Izokibep in Patients with Psoriatic Arthritis
05/02/22
Therapeutic Solutions International Announces Launching of Phase III Clinical Trial for Treating COVID-19 Lung Damage Using its JadiCell™ Universal Donor Stem Cell Drug
05/02/22
Orna Therapeutics to Present Novel, First-in-Class Circular RNA Data at Upcoming ASGCT 2022 Annual Meeting
05/02/22
NKGen Biotech Announces Three SNK01 Abstracts to be Presented at the 2022 ASCO Annual Meeting
05/02/22
Forge Biologics Announces 7 Presentations at the Upcoming Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
05/02/22
EdiGene to Present getools, a Data Analysis Software Toolkit for Advanced Analytics of DNA and RNA Editing Efficiency and Outcomes for Therapeutic Development at the ASGCT 25th Annual Meeting
05/02/22
CERo Therapeutics’ Multifunctional CER T Cells Synergize with Standard-of-Care Small Molecule Anti-Tumor Inhibitors Across Hematologic and Solid Tumor Models
05/02/22
Catamaran Bio to Present Preclinical Data at ASGCT Annual Meeting to Support CAR-NK Approach for Solid Tumors
People
05/05/22
Artiva Biotherapeutics Appoints Edith A. Perez, M.D., to Its Board of Directors and Clinical Advisory Board
05/04/22
LinKinVax Appoints Dr. Jiong Ma as Independent Board Member
05/04/22
Julianne Averill and Kristen Richardson Join Anji Pharma to Ready Company for Next Stage of Growth
05/03/22
Seismic Therapeutic Appoints Maude Tessier, PhD, as Chief Business Officer
05/03/22
Curebase Named Honorable Mention in Best World Changing Idea NA Category of Fast Company's 2022 World Changing Ideas Awards
05/02/22
Ventus Therapeutics Appoints Stuart Green, M.D., as Chief Medical Officer
05/02/22
Gordon Robert Alton, PhD Joins BriOri BioTech as COO to Develop Patented Topical Formulation of Vioxx Providing Those Suffering with Osteoarthritis a Long Lasting Non-Opioid Option for Pain Relief
04/27/22
Catamaran Bio Appoints Cherry Thomas, MD, as Chief Medical Officer
04/26/22
Vedere Bio II Appoints Accomplished Clinician and Researcher Anna-Maria Demetriades as Chief Medical Officer
04/26/22
ROME Therapeutics Appoints Nurjana Bachman, Ph.D., as Senior Vice President, Corporate Development and Strategy
04/26/22
Flare Therapeutics Appoints Adrian Jubb as Chief Medical Officer
04/26/22
Adaptive Phage Therapeutics Appoints Rob Casper as Vice President of Clinical Operations
04/25/22
RayzeBio Appoints Angie You, Ph.D., to its Board of Directors
04/25/22
Carisma Therapeutics Announces Appointment Of Michael Klichinsky, PharmD, PhD, As Chief Scientific Officer
04/25/22
Biotheryx Announces Appointment of Jeff Caravella as Chief Financial Officer
04/25/22
AffyImmune Therapeutics Announces Hiring of Dr. Sonal Gupta as Senior Vice President and Head of Clinical Development
04/21/22
Maxwell Biosciences Announces the Appointment of Edward Rudnic, Ph.D., as Chief Operating Officer
04/20/22
Ambys Medicines Expands Leadership Team with Key Appointments in Human Resources and Finance Functions
04/20/22
Vaxxas Announces Appointment of Scott Fry Ph.D. as Chief Operating Officer
04/19/22
Omniose Announces Expanded Leadership Team to Develop Bioconjugate Vaccines Against Serious Bacterial Threats
04/19/22
eGenesis Promotes Michael Curtis, Ph.D., to Chief Executive Officer
04/19/22
Turnstone Biologics Announces Executive Leadership Appointments